Vitamin D and hypertension: Prospective study and meta-analysis

Objectives The study sought to determine the link between vitamin D concentrations and incident hypertension in prospective study and meta-analysis. Methods The study was embedded in the Kailuan Study, a population-based cohort of adults that contains underground miners. In 2012, we studied 2,456 men and women free of prevalent hypertension, age 21 to 67 at baseline. Serum 25-hydroxyvitamin D was measured from previously frozen baseline samples using ELISA (Enzyme-Linked ImmunoadSorbent Assay). We use the logistic regression analysis to estimate the odd radio (ORs) 95% confidence intervals (CIs) for 25-hydroxyvitamin D [25(OH)D] concentrations with incident hypertension. To help place our new data in context, we conducted a systemic review and meta-analysis of previous prospective reports of vitamin D and hypertension. Results During a median follow-up of 2 years, 42.6% of the cohort (n = 1047) developed hypertension. Compared with the 25-hydroxyvitamin D >30ng/ml, 25-hydroxyvitamin D <20 ng/ml was associated with a greater hypertension risk (OR: 1.225 [95% CI: 1.010 to 1.485] p = 0.04), although the association was attenuated and not statistically significant after adjusting for potential confounders (OR: 1.092 [95% CI: 0.866 to 1.377] p = 0.456). This meta-analysis included seven prospective studies for 53,375 participants using adjusted HR founded a significant association between vitamin D deficiencies and incident hypertension (HRs = 1.235 (95% CI: 1.083 to 1.409, p = 0.002)). Conclusion Lower serum 25-hydroxyvitamin D concentrations were not associated with a greater risk of incident hypertension. More research is needed to further determine the role of 25-hydroxyvitamin D in hypertension prevention and therapy.

[1]  Shouling Wu,et al.  Long Sleep Duration and Risk of Ischemic Stroke and Hemorrhagic Stroke: the Kailuan Prospective Study , 2016, Scientific Reports.

[2]  Yuming Guo,et al.  Cumulative Exposure to Ideal Cardiovascular Health and Incident Diabetes in a Chinese Population: The Kailuan Study , 2016, Journal of the American Heart Association.

[3]  Shuohua Chen,et al.  Changes in ideal cardiovascular health status and risk of new-onset type 2 diabetes , 2016, Medicine.

[4]  Wei Li,et al.  Classical and non‐classical metabolic transformation of vitamin D in dermal fibroblasts , 2016, Experimental dermatology.

[5]  Wei Li,et al.  Detection of novel CYP11A1-derived secosteroids in the human epidermis and serum and pig adrenal gland , 2015, Scientific Reports.

[6]  K. Chien,et al.  Total 25-Hydroxyvitamin D Concentration as a Predictor for All-Cause Death and Cardiovascular Event Risk among Ethnic Chinese Adults: A Cohort Study in a Taiwan Community , 2015, PloS one.

[7]  G. Reaven,et al.  Relationship among 25-hydroxyvitamin D concentrations, insulin action, and cardiovascular disease risk in patients with essential hypertension. , 2015, American journal of hypertension.

[8]  M. Dibley,et al.  Modifiable risk factors including sunlight exposure and fish consumption are associated with risk of hypertension in a large representative population from Macau , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[9]  Wei Li,et al.  The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[10]  B. Kestenbaum,et al.  Association of 25-hydroxyvitamin D and parathyroid hormone with incident hypertension: MESA (Multi-Ethnic Study of Atherosclerosis). , 2014, Journal of the American College of Cardiology.

[11]  T. MacDonald,et al.  Vitamin D Therapy to Reduce Blood Pressure and Left Ventricular Hypertrophy in Resistant Hypertension: Randomized, Controlled Trial , 2014, Hypertension.

[12]  S. Tonstad,et al.  Relationship of vitamin D levels to blood pressure in a biethnic population. , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[13]  C. Wagner,et al.  Dietary vitamin D restriction in pregnant female mice is associated with maternal hypertension and altered placental and fetal development. , 2013, Endocrinology.

[14]  S. Weng,et al.  Vitamin D Deficiency Induces High Blood Pressure and Accelerates Atherosclerosis in Mice , 2013, PloS one.

[15]  Duane D. Miller,et al.  Novel vitamin D photoproducts and their precursors in the skin , 2013, Dermato-endocrinology.

[16]  J. Manson,et al.  A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men , 2013, European Journal of Nutrition.

[17]  T. Jørgensen,et al.  Vitamin D Status and Changes in Cardiovascular Risk Factors: A Prospective Study of a General Population , 2012, Cardiology.

[18]  Li-hua Li,et al.  Vitamin D, Parathyroid Hormone and Their Associations with Hypertension in a Chinese Population , 2012, PloS one.

[19]  W. März,et al.  Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. , 2012, Cardiovascular research.

[20]  A. Vaidya,et al.  The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes. , 2012, Metabolism: clinical and experimental.

[21]  Y. Xiang,et al.  Circulating 25-hydroxyvitamin D levels in relation to blood pressure parameters and hypertension in the Shanghai Women's and Men's Health Studies , 2012, British Journal of Nutrition.

[22]  J. Woo,et al.  Serum 25-hydroxyvitamin D and parathyroid hormone levels in relation to blood pressure in a cross-sectional study in older Chinese men , 2012, Journal of Human Hypertension.

[23]  D. Eyles,et al.  Vitamin D insufficiency is associated with impaired vascular endothelial and smooth muscle function and hypertension in young rats , 2011, The Journal of physiology.

[24]  S. Larsson,et al.  Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis , 2011, Journal of hypertension.

[25]  C. Gadegbeku,et al.  Vitamin D and subsequent systolic hypertension among women. , 2011, American journal of hypertension.

[26]  D. Bikle,et al.  Vitamin D: an ancient hormone , 2011, Experimental dermatology.

[27]  B. Horne,et al.  Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. , 2010, The American journal of cardiology.

[28]  P. Vanhoutte,et al.  Chronic treatment with vitamin D lowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. , 2010, American journal of physiology. Heart and circulatory physiology.

[29]  G. Curhan,et al.  Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension Among Young Women , 2008, Hypertension.

[30]  J. Manson,et al.  Effect of Calcium and Vitamin D Supplementation on Blood Pressure: The Women's Health Initiative Randomized Trial , 2008, Hypertension.

[31]  M. Holick,et al.  Vitamin D deficiency: a worldwide problem with health consequences. , 2008, The American journal of clinical nutrition.

[32]  P. Vestergaard,et al.  Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis , 2008, Osteoporosis International.

[33]  Edward Giovannucci,et al.  Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension , 2007, Hypertension.

[34]  R. Simpson,et al.  Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[35]  P. Lips,et al.  13th Workshop consensus for vitamin D nutritional guidelines , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[36]  R. Jorde,et al.  Insulin sensitivity in subjects with secondary hyperparathyroidism and the effect of a low serum 25-hydroxyvitamin D level on insulin sensitivity , 2007, Journal of endocrinological investigation.

[37]  M. Holick.  Vitamin D: Important for Prevention of Osteoporosis, Cardiovascular Heart Disease, Type 1 Diabetes, Autoimmune Diseases, and Some Cancers , 2005, Southern medical journal.

[38]  A. Sanabria,et al.  Randomized controlled trial. , 2005, World journal of surgery.

[39]  Yan Chun Li.  Vitamin D regulation of the renin–angiotensin system , 2003, Journal of cellular biochemistry.

[40]  M. Holick.  Vitamin D: A millenium perspective , 2003, Journal of cellular biochemistry.

[41]  I. Benter,et al.  Central nervous system is not involved in initiation of the pressor effect of 7-nitroindazole in urethane-anesthetized rats. , 1998, Hypertension.

[42]  C. Bell,et al.  Ultraviolet light may contribute to geographic and racial blood pressure differences. , 1998, Hypertension.

[43]  S. Rostand.  Ultraviolet light may contribute to geographic and racial blood pressure differences. , 1997, Hypertension.

[44]  Martyn Plummer,et al.  Seasonal variation of blood pressure and its relationship to ambient temperature in an elderly population , 1993, Journal of hypertension.

[45]  P. Whelton,et al.  The association of skin color with blood pressure in US blacks with low socioeconomic status. , 1991, JAMA.

[46]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.